Loading
santec Holdings株式会社 Stock: price and insider trades · Japan
santec Holdings株式会社: what insiders have been doing
Insider filings for santec Holdings株式会社 are scarce in the EDINET (Japan FSA) feed, the latest one published on 19 May 2023. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
Key facts
Headquarters: Japan · Founded: 1979
Source: Wikidata (CC0).
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 4,736 of 23,476 companies
66.8
score / 100
Value47
Quality87
FCF yld3.2%
Earn yld3.8%
EV/EBITDA18.1x
ROE31%
Gross mgn58%
Net mgn24%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
JP¥17,280
Analyst consensus
Income statement
RevenueJP¥31.5B
Gross profitJP¥18.2B58% margin
EBITDAJP¥11.4B36% margin
Net incomeJP¥7.7B24.3% margin
Valuation
PER (trailing)26.5x
P/Book7.3x
Beta1.19
Balance sheet & cash
Market capJP¥203.2B
Total debtJP¥2.8B
Free Cash FlowJP¥6.5B
Debt / Equity10%
Profitability & ownership
ROE31.1%
ROA18.8%
% insiders56.2%
% institutions6.1%
Last declaration on 19 May 2023
Declarations3 total
ShareXTKSEDINET:S100QRZJ
100.0% of flowShareXTKSEDINET:S100QRZD
100.0% of flowShareXTKSEDINET:S100QRZ3
3 of 3 declarations
About santec Holdings株式会社
santec Holdings is a company operating in the healthcare and pharmaceutical sector, listed on the XTKS market. It focuses on the development and distribution of innovative pharmaceutical products.